TONEVA
Face Serum
A clinical-strength formulation engineered to significantly reduce the appearance of melasma, persistent dark spots, and post-inflammatory hyperpigmentation. Features our proprietary Molecular Brightening complex for 360° radiance.
Triple Action Clinical Efficacy
Designed for aesthetic practitioners, TONEVA delivers targeted results through a multi-pathway approach to melanin regulation.
Melasma Reduction
Specifically targets stubborn epidermal pigmentation by inhibiting tyrosinase activity and interrupting melanin transfer.
Dark Spot Correction
Accelerates cellular turnover to fade existing hyperpigmentation, including PIH from acne and photo-damage.
360° Radiance
Enhances overall dermal luminosity and evens skin texture, providing a comprehensive brightening effect.
Active Ingredient Profile
A highly concentrated, synergistic blend of clinically proven depigmenting agents formulated at optimal pH levels for maximum bioavailability and efficacy without irritation.
CLINICAL NOTE
Suitable for integration into professional chemical peel and microneedling protocols.
-
10%
Liposomal Azelaic Acid
Normalizes keratinization and exhibits strong anti-inflammatory properties while targeting hyperactive melanocytes.
-
5%
Niacinamide
Inhibits melanosome transfer from melanocytes to keratinocytes and reinforces the epidermal barrier function.
-
3%
Tranexamic Acid (Liposomal | Envy | Nano)
Prevents plasminogen binding to keratinocytes, effectively reducing melanin synthesis induced by UV exposure and hormonal changes.
-
2%
Alpha Arbutin
A highly stable glycosylated hydroquinone derivative that safely inhibits tyrosinase oxidation.
-
0.5%
4-butylresorcinol
-
0.3%
Hyaluronic Acid